Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
United States
Pharma
Hansa eyes US listing ahead of FDA verdict on Idefirix
With the FDA expected to decide on its kidney transplant drug before year-end, Hansa Biopharma is mulling its stock listing options in the U.S.
Fraiser Kansteiner
Aug 24, 2026 2:45pm
WuXi AppTec wins temporary relief in DOD classification feud
Aug 11, 2026 11:33am
BeOne joins reshoring parade with $300M US production expansion
Jul 23, 2026 11:18am
Trump floats countdown to 200% tariff rate on imported generics
Jul 22, 2026 11:00am
Germany approves controversial healthcare reform package
Jul 13, 2026 10:40am
Shionogi's Japan-approved antiviral nets US COVID nod
Jun 1, 2026 11:11am
